Status:
WITHDRAWN
Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies
Lead Sponsor:
Sheba Medical Center
Collaborating Sponsors:
Tel Aviv University
Conditions:
Ovarian Cancer
Primary Peritoneal Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Oncologic patients often report increased fatigue during and after chemotherapy. Evidence suggests Tai-chi/Qi-gong may improve quality of life (QOL) in oncologic patients treated with chemotherapy. Pr...
Detailed Description
Tai-chi/Qi-gong is a complementary medicine technique that synergizes the mind-body connection. The technique employs a series of positions and movements that are performed in a slow, flowing manner t...
Eligibility Criteria
Inclusion
- Women with gynecological malignancies undergoing primary or secondary chemotherapy
Exclusion
- Motor disability;
- Less than 1 month since the last abdominal surgery;
- Ascites
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01880996
Start Date
August 1 2014
End Date
August 1 2015
Last Update
June 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Hospital
Ramat Gan, Israel